VACCINOGEN INC
Biotechnology · Frederick, MD
Data ndekọ gọọmentị
0ndị na-eso
2007tọrọ ntọala
Maka VACCINOGEN INC
Vaccinogen Inc. is a US biotechnology company based in Baltimore. It is currently developing a potential cancer immunotherapy called OncoVAX, where a patient's own tumor cells are used as the vaccine, adjuvanted by BCG. This product was evaluated in Phase III in colon cancer in the 1990s and another Phase III study, called ACTIVE, is currently recruiting stage II colon cancer patients. Vaccinogen calls its approach 'Active Specific Immunotherapy' or ASI.
Source: Wikipedia
NgalabaBiotechnology
Isi ụlọ ọrụFrederick, MD
Tọrọ ntọala2007
Ụdị iwuC Corporation
ỌnọdụNa-arụ ọrụ
Nyocha
Enweghị nyocha ugbu a. Ị rụrụ ọrụ na VACCINOGEN INC? Bụrụ onye mbụ kekọrịta ahụmahụ gị.
Ọnụọgụ isi
Banye iji hụ ọnụ ọgụgụ ndị isi
Ego mbata, uru net na ọnụ ọgụgụ ndị ọrụ nke VACCINOGEN INC ka afọ na-aga, tinyere isi mmalite ha.
Banye Mepụta akaụntụ site n'ozi-e gịỌ bụ n'efu
Site n'ịga n'ihu, ị na-ekweta Nkwekọrịta onye ojiji, Amụma nzuzo na Amụma kuki nke Heelky.
Ozi iwu
| Aha iwu | VACCINOGEN INC |
|---|---|
| Ụdị iwu | C Corporation |
| SEC CIK | 1453001Lee na SEC EDGAR ↗ |
| Adreesị edebanyere aha | Frederick, MD |
| Ọnọdụ | Na-arụ ọrụ |
Isi mmalite: SEC EDGAR · emelitere 14 Nọvemba 2026
Kọntaktị & njikọ
Ebe
Frederick, MD
Nke a ọ bụ ụlọ ọrụ gị?
Kwuo ibe a n'efu iji tinye logo gị, ngwaahịa, foto na ọrụ, na iza nyocha.
Kwuo ibe aSonye na Heelky iji jikọọ, were ndị ọrụ ma too
Mepụta akaụntụ efu iji zipụ ndị mmadụ ozi, tinye arịrịọ ọrụ ma bipụta mishọn.
Sonye ugbu a — ọ bụ n'efu